Liposuction helps manage lymphedema in head and neck cancer

Share this article:
Liposuction is a simple, uncomplicated, and well-tolerated surgical technique for the treatment of persistent submental lymphedema in patients with a previous head and neck cancer, a small study has demonstrated.

Submental lymphedema, which affects the area under the chin and commonly develops among persons who have undergone treatment for head and neck cancer, causes fluid deposition and persistent swelling of the soft tissues of the neck. This leads to disfigurement and functional deficits, according to a statement issued by the American Academy of Otolaryngology – Head and Neck Surgery, which published the study results in the association's journal, Otolaryngology—Head and Neck Surgery (2012;146[6]:1028-1030).

As S. Mark Taylor, MD, and Maria Brake, MD, of Dalhousie University, Halifax, Nova Scotia, Canada, noted in their report, the use of liposuction for submental and cervical lymphedema had never been described in the literature to their knowledge. The pair performed submental liposuction on 10 patients experiencing persistent lymphedema after having undergone radiotherapy for a head and neck malignancy. Five patients had previous neck dissection, one of which was radical. All of the participants had been cancer-free for at least 1 year prior to the liposuction. The procedure involved an incision being made into the neck, after which liposuction was applied to remove fat and fluid from the treatment area.

All the patients tolerated the procedure well under local anesthesia, with no complications by the time Taylor and Brake wrote up their findings. No recurrences in the neck had developed, and all 10 patients reported being satisfied with the results and said they would recommend the procedure it to other patients.

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Immunotherapy added to radiotherapy may help overcome resistance to treatments

Coupling immunotherapy to radiotherapy treatment could help prevent cancers from becoming resistant to treatment, according to a new study.

Companion diagnostic test improves detection of BRCA mutations in patients with ovarian ...

The Tumor BRACAnalysis CDx companion diagnostic test boosted the detection of cancer-causing BRCA1/2 mutations in women with ovarian cancer by over 40 percent.

Landmark Medicare law had little impact on reducing chemotherapy cost

Legislation passed in 2003 intended to slow the spiraling costs of drugs paid for by the federal government to treat Medicare patients has not proved to be a success.